Immunovia AB Stock
Stocks
IMMNOV
SE0006091997
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
19:00:00 11/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.1428 SEK | +0.56% |
|
+10.19% | -37.09% |
| 09-03 | Six stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| 09-01 | 17 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| Market Cap | 96.06M 9.91M 8.54M 8.09M 7.33M 13.75M 947M 13.82M 36.94M 482M 37.23M 36.41M 1.52B | P/E 2026 * |
-1.43x | P/E 2027 * | -3.57x |
|---|---|---|---|---|---|
| Enterprise Value | 61.06M 6.3M 5.43M 5.14M 4.66M 8.74M 602M 8.79M 23.48M 306M 23.67M 23.15M 968M | EV / Sales 2026 * |
19.1x | EV / Sales 2027 * | 3.82x |
| Free-Float |
90.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| IMMNOV | Delayed | |
OTC Markets
| IMMVF | Delayed | |
|
CBOE
| IMMNOs | Real-time | |
|
CBOE
| 0G8X | Real-time | |
|
Deutsche Boerse AG
| 1YR | Delayed | |
|
Boerse Muenchen
| 1YR | Real-time |
Last Transcript : Immunovia AB
| 1 day | +0.56% | ||
| 1 week | +10.19% | ||
| Current month | +1.42% | ||
| 1 month | -11.96% | ||
| 3 months | -20.49% | ||
| 6 months | -11.41% | ||
| Current year | -37.09% |
| 1 week | 0.13 |  | 0.18 |
| 1 month | 0.12 | | 0.18 |
| Current year | 0.12 | | 0.25 |
| 1 year | 0.12 | | 0.72 |
| 3 years | 0.12 | | 4.73 |
| 5 years | 0.12 | | 137.3 |
| 10 years | 0.12 | | 298.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | 53 | 29/04/2023 |
Lisa Ford
CTO | Chief Tech/Sci/R&D Officer | 55 | 29/04/2024 |
| Chief Tech/Sci/R&D Officer | 54 | 31/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 09/12/2016 | |
Peter Andersen
CHM | Chairman | 69 | 26/05/2023 |
| Director/Board Member | 51 | 01/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/15/22 A | Buy | Chief Executive Officer | 150,000 | 0.6628% | ||
| 5/24/22 A | Buy | Chief Executive Officer | 100,000 | 0.4419% | ||
| 5/21/22 A | Buy | Chief Executive Officer | 100,000 | 0.4419% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.56% | +10.19% | -77.51% | -80.08% | 9.91M | |
| +0.87% | -1.81% | +20.83% | -28.73% | 16.73B | |
| -1.77% | +5.22% | -35.05% | +55.90% | 1.75B | |
| +0.08% | -4.28% | -28.36% | +24.66% | 893M | |
| -3.05% | -15.68% | -58.77% | -84.02% | 808M | |
| -0.05% | -0.27% | +63.36% | -1.86% | 778M | |
| -2.56% | -5.17% | -38.85% | -50.56% | 637M | |
| -5.26% | -9.59% | -43.32% | -52.47% | 560M | |
| +3.41% | -14.92% | -44.30% | -37.49% | 450M | |
| +2.02% | +0.62% | -7.77% | -7.88% | 397M | |
| Average | -0.58% | -3.29% | -24.97% | -26.25% | 2.3B | |
| Weighted average by Cap. | +0.30% | -2.06% | +8.29% | -22.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.2M 330K 285K 269K 244K 458K 31.55M 460K 1.23M 16.05M 1.24M 1.21M 50.72M | 17.3M 1.79M 1.54M 1.46M 1.32M 2.48M 171M 2.49M 6.65M 86.78M 6.71M 6.56M 274M |
| Net income | -87M -8.98M -7.74M -7.33M -6.64M -12.46M -858M -12.52M -33.46M -436M -33.72M -32.98M -1.38B | -76M -7.84M -6.76M -6.4M -5.8M -10.88M -749M -10.94M -29.23M -381M -29.46M -28.81M -1.2B |
| Net Debt | -35M -3.61M -3.11M -2.95M -2.67M -5.01M -345M -5.04M -13.46M -176M -13.57M -13.27M -555M | -30M -3.1M -2.67M -2.53M -2.29M -4.3M -296M -4.32M -11.54M -150M -11.63M -11.37M -476M |
Employees
18
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | SEK 0.1428 | +0.56% | 2,202,786 |
| 10/09/26 | SEK 0.1420 | -4.18% | 1,955,787 |
| 09/09/26 | SEK 0.1482 | -1.20% | 3,009,698 |
| 08/09/26 | SEK 0.1500 | -10.50% | 7,740,306 |
| 07/09/26 | SEK 0.1676 | +29.32% | 14,614,449 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMMNOV Stock
Select your edition
All financial news and data tailored to specific country editions
